Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,533 | 14 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $454.99 | 4 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $245.68 | 2 | $0 (2024) |
| Allergan Inc. | $135.53 | 1 | $0 (2017) |
| PORTOLA PHARMACEUTICALS, INC. | $124.99 | 1 | $0 (2019) |
| Vapotherm Inc | $121.62 | 1 | $0 (2019) |
| Grifols USA, LLC | $120.24 | 1 | $0 (2018) |
| Nabriva Therapeutics, plc | $99.66 | 1 | $0 (2020) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $93.86 | 1 | $0 (2018) |
| Collegium Pharmaceutical, Inc. | $74.97 | 1 | $0 (2017) |
| Genentech USA, Inc. | $61.94 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $262.52 | 2 | Janssen Pharmaceuticals, Inc ($140.68) |
| 2023 | $123.84 | 1 | AstraZeneca Pharmaceuticals LP ($123.84) |
| 2022 | $123.84 | 1 | Janssen Pharmaceuticals, Inc ($123.84) |
| 2021 | $123.80 | 1 | Janssen Pharmaceuticals, Inc ($123.80) |
| 2020 | $99.66 | 1 | Nabriva Therapeutics, plc ($99.66) |
| 2019 | $246.61 | 2 | PORTOLA PHARMACEUTICALS, INC. ($124.99) |
| 2018 | $342.71 | 4 | Grifols USA, LLC ($120.24) |
| 2017 | $210.50 | 2 | Allergan Inc. ($135.53) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/23/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $121.84 | General |
| Category: Rare Disease | ||||||
| 03/13/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $140.68 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/20/2023 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $123.84 | General |
| Category: Rare Disease | ||||||
| 04/19/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $123.84 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/16/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $123.80 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/03/2020 | Nabriva Therapeutics, plc | Xenleta (Drug) | Food and Beverage | In-kind items and services | $99.66 | General |
| Category: Antibiotic | ||||||
| 06/27/2019 | Vapotherm Inc | Precision Flow (Device) | Food and Beverage | In-kind items and services | $121.62 | General |
| Category: Respiratory | ||||||
| 03/20/2019 | PORTOLA PHARMACEUTICALS, INC. | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: HEMATOLOGY/NEUROLOGY | ||||||
| 08/22/2018 | Grifols USA, LLC | HyperRAB SD (Biological) | Food and Beverage | In-kind items and services | $120.24 | General |
| Category: Immunology | ||||||
| 06/28/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $93.86 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/29/2018 | Genentech USA, Inc. | Activase (Biological) | Food and Beverage | In-kind items and services | $61.94 | General |
| Category: Metabolism & Primary Care | ||||||
| 02/22/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $66.67 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/20/2017 | Collegium Pharmaceutical, Inc. | Xtampza ER (Drug) | Food and Beverage | Cash or cash equivalent | $74.97 | General |
| Category: Opioid Analgesic | ||||||
| 02/22/2017 | Allergan Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $135.53 | General |
| Category: ANTI-INFECTIVE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 2 | 66 | 67 | $45,661 | $6,359 |
| 2020 | 5 | 307 | 311 | $192,555 | $29,599 |
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 38 | 38 | $44,002 | $6,164 | 14.0% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 28 | 29 | $1,659 | $194.88 | 11.7% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 126 | 127 | $124,841 | $18,783 | 15.0% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 35 | 35 | $40,740 | $6,937 | 17.0% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 24 | 25 | $16,550 | $2,523 | 15.2% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 110 | 112 | $5,600 | $764.87 | 13.7% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 12 | 12 | $4,824 | $591.44 | 12.3% |
About Dr. Anthony Pidala, MD
Dr. Anthony Pidala, MD is a Emergency Medicine healthcare provider based in Tampa, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1942237540.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anthony Pidala, MD has received a total of $1,533 in payments from pharmaceutical and medical device companies, with $262.52 received in 2024. These payments were reported across 14 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($1,533).
As a Medicare-enrolled provider, Pidala has provided services to 373 Medicare beneficiaries, totaling 378 services with total Medicare billing of $35,958. Data is available for 2 years (2020–2021), covering 7 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Location Tampa, FL
- Active Since 06/27/2006
- Last Updated 08/03/2009
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1942237540
Products in Payments
- XARELTO (Drug) $454.99
- ANDEXXA (Biological) $370.67
- TEFLARO (Drug) $135.53
- Precision Flow (Device) $121.62
- HyperRAB SD (Biological) $120.24
- Xenleta (Drug) $99.66
- XIFAXAN (Drug) $93.86
- Xtampza ER (Drug) $74.97
- Activase (Biological) $61.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Tampa
Jason Wilson, Md, MD
Emergency Medicine — Payments: $720,441
Michael Sore, M.d, M.D
Emergency Medicine — Payments: $121,000
Dr. Juan Gallego, M.d, M.D
Emergency Medicine — Payments: $60,385
David Wein, M.d, M.D
Emergency Medicine — Payments: $43,346
Dr. Pushpal Banerjee, Do, DO
Emergency Medicine — Payments: $19,639
Dr. Michael Lozano, Md, MD
Emergency Medicine — Payments: $5,740